Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHG Regimen vs Decitabine in Higher-risk MDS
NCT01417767Phase 3Unknown
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Cytokines & Interferons, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cytarabine, homoharringtonine, granulocyte colony-stimulating factor in myelodysplastic syndrome (MDS). Status: unknown.
02
Drugs
cytarabinehomoharringtoninegranulocyte colony-stimulating factor
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01417767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01417767.